Posts Tagged ‘me/cfs biomarkers’
Progress in ME/CFS Subset Identification
When it comes to biomarker discovery and clinical trials, disease heterogeneity is the bane of clinical researchers existence. I am showing my age here, but think of it like static on the radio: too much noisy static makes it hard to hear the nice music sound and when you tune in, the signal is loud…
Read MoreA Consensus-Driven ME/CFS Clinician Coalition Takes Shape
On March 2-3, 2018, the Bateman Horne Center hosted an exciting summit of leading U.S. ME/CFS clinicians who came together to share their pearls of wisdom on diagnosis and treatment in order to improve ME/CFS clinical care and refine more precise research targets. The meeting was remarkable for the ambitious nature of the agenda, the enthusiastic…
Read MoreStandardizing Measurement of ME/CFS Core Symptoms
Dr. Suzanne D. Vernon, BHC research liaison, explains how the IOM report defining the core symptoms of ME/CFS also define the BHC research roadmap. ________ At the October 2012 CFS Advisory Committee meeting Dr. Sandra Kweder, Deputy Director of the Office of New Drugs at the FDA stated, “When there is confusion, lack of consensus…
Read MoreBHC Raises $1.08 Million, Moving to New Facility!
We’re Moving! In our spring campaign we laid out an audacious goal to raise $300,000 that would allow us to move into a larger facility in order to serve more patients, expand education efforts, and increase research participation. We are thrilled to announce that we have exceeded our goal by more than 260%, raising more than…
Read MoreBHC Collaborates on NIH Funded Study to Identify ME/CFS Antibody Biomarkers
A $200,000 grant from National Institute of Allergy and Infectious Diseases has been awarded for a study seeking to identify antibody biomarkers for ME/CFS. The Bateman Horne Center will partner with Armin Alaedini, PhD on this important research. By Suzanne D Vernon We know ME/CFS is a very heterogeneous condition with different causes and different constellation of…
Read More